Src42A modulates tumor invasion and cell death via Ben/dUev1a-mediated JNK activation in Drosophila

X Ma1, Y Shao, H Zheng

  • 1Department of Interventional Radiology, Shanghai Key Laboratory of Signaling and Disease Research, Shanghai 10th People's Hospital, School of Life Science and Technology, Tongji University, Shanghai 200092, China.

Cell Death & Disease
|October 19, 2013
PubMed

Insights

Loss of cell polarity genes and oncogenic Ras cooperate to drive tumor invasion, modulated by Src42A and the JNK pathway. The Bendless/dUev1a complex is crucial for this Src42A-induced migration and invasion.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Oncology

Background:

  • Cell polarity loss cooperates with oncogenic Ras to drive tumor growth and invasion.
  • The c-Jun N-terminal Kinase (JNK) signaling pathway is critical for Ras-driven tumor invasion.

Purpose of the Study:

  • Identify key modulators of Ras/polarity loss-driven tumor invasion and cell migration.
  • Investigate the role of the Bendless (Ben)/dUev1a ubiquitin E2 complex in Src42A-induced, JNK-mediated cell migration.
  • Explore the oncogenic potential of Ben/dUev1a and its mammalian homologs.

Main Methods:

  • Genetic screening in Drosophila to identify novel regulators.
  • Analysis of gene interactions in tumor growth and invasion models.
  • Assessment of cell migration, MMP1 production, and cell death.

Main Results:

  • Src42A identified as a key modulator of tumor invasion and cell migration.
  • The Ben/dUev1a complex is essential for Src42A-induced, JNK-mediated cell migration.
  • Ectopic Ben/dUev1a expression promotes invasive migration and MMP1 production.
  • Ben/dUev1a cooperates with Ras(V12) to promote tumor overgrowth and invasion.
  • Ben/dUev1a is required for Src42A-induced cell death and thorax closure.

Conclusions:

  • Src42A and the Ben/dUev1a complex play significant roles in developmental processes and tumor progression.
  • The study provides mechanistic insights into Src function in development and disease.
  • Mammalian Ubc13 and Uev1a may possess oncogenic functions.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K